Amaryl: Advanced Glycemic Control for Type 2 Diabetes
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.44 | $43.17 (0%) | 🛒 Add to cart |
| 60 | $1.12 | $86.34 $67.27 (22%) | 🛒 Add to cart |
| 90 | $1.02 | $129.52 $91.36 (29%) | 🛒 Add to cart |
| 120 | $0.96 | $172.69 $115.46 (33%) | 🛒 Add to cart |
| 180 | $0.91 | $259.03 $164.66 (36%) | 🛒 Add to cart |
| 270 | $0.87 | $388.55 $235.94 (39%) | 🛒 Add to cart |
| 360 | $0.86
Best per pill | $518.07 $311.24 (40%) | 🛒 Add to cart |
| Product dosage: 3mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.64 | $49.20 (0%) | 🛒 Add to cart |
| 60 | $1.31 | $98.39 $78.31 (20%) | 🛒 Add to cart |
| 90 | $1.18 | $147.59 $106.42 (28%) | 🛒 Add to cart |
| 120 | $1.12 | $196.78 $134.54 (32%) | 🛒 Add to cart |
| 180 | $1.07 | $295.18 $191.76 (35%) | 🛒 Add to cart |
| 270 | $1.03 | $442.77 $279.11 (37%) | 🛒 Add to cart |
| 360 | $1.01
Best per pill | $590.35 $364.45 (38%) | 🛒 Add to cart |
Amaryl (glimepiride) is a second-generation sulfonylurea oral antidiabetic medication designed to support the management of type 2 diabetes mellitus. By stimulating insulin release from pancreatic beta cells and increasing peripheral tissue sensitivity to insulin, it effectively helps lower blood glucose levels. It is commonly prescribed as part of a comprehensive treatment plan that includes diet, exercise, and, when necessary, other glucose-lowering agents. Suitable for adult patients, Amaryl offers a reliable therapeutic option for those struggling to achieve target HbA1c levels through lifestyle modifications alone.
Features
- Active ingredient: Glimepiride
- Available in tablet strengths: 1 mg, 2 mg, 3 mg, 4 mg, 6 mg, and 8 mg
- Administration: Oral, once daily
- Mechanism: Sulfonylurea class—insulin secretagogue
- Onset of action: Within 1 hour
- Duration: Up to 24 hours
- Excretion: Primarily hepatic and renal
Benefits
- Effectively reduces fasting and postprandial blood glucose levels
- Helps achieve and maintain target HbA1c levels
- Convenient once-daily dosing supports adherence
- May be used as monotherapy or in combination with other antidiabetic agents
- Contributes to long-term reduction in diabetes-related complications
- Supports individualized glycemic targets through flexible dosing
Common use
Amaryl is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is often prescribed when metformin is not tolerated or is contraindicated, or when additional glycemic control is needed. It may also be used in combination therapy with other oral antidiabetics or insulin.
Dosage and direction
The initial dose is usually 1–2 mg once daily, taken with breakfast or the first main meal. Dosage should be adjusted based on blood glucose response, in increments of 1–2 mg at 1–2 week intervals. The usual maintenance dose is 1–4 mg daily; the maximum recommended dose is 8 mg once daily. Regular monitoring of blood glucose and HbA1c is advised to determine the optimal dose.
Precautions
- Risk of hypoglycemia, especially in elderly, debilitated, or malnourished patients
- Regular liver and kidney function tests recommended
- Use with caution in patients with G6PD deficiency due to risk of hemolytic anemia
- May cause weight gain
- Not recommended during pregnancy or breastfeeding
- Inform healthcare provider prior to surgery or acute medical conditions
Contraindications
- Hypersensitivity to glimepiride or other sulfonylureas
- Type 1 diabetes mellitus
- Diabetic ketoacidosis
- Severe renal or hepatic impairment
- Concomitant use of bosentan
Possible side effect
- Hypoglycemia
- Dizziness
- Headache
- Nausea
- Allergic skin reactions (e.g., pruritus, erythema)
- Weight gain
- Visual disturbances
- Gastrointestinal discomfort
Drug interaction
- Enhanced hypoglycemic effect with: insulin, other sulfonylureas, metformin, thiazolidinediones, ACE inhibitors, fibrates, fluoxetine, MAO inhibitors, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins
- Reduced hypoglycemic effect with: thiazides, corticosteroids, thyroid products, sympathomimetics, calcium channel blockers, estrogens, oral contraceptives, phenytoin, nicotinic acid, isoniazid
- Potential for interactions with warfarin and other highly protein-bound drugs
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is near the time of the next dose, skip the missed dose and resume the usual dosing schedule. Do not double the dose.
Overdose
Symptoms of overdose include severe hypoglycemia, which may present as confusion, tremors, sweating, rapid heartbeat, vision changes, seizure, or loss of consciousness. Management includes immediate intake of oral glucose or administration of intravenous glucose or glucagon. Hospitalization and close monitoring may be required.
Storage
Store at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and moisture. Keep out of reach of children. Do not use after the expiration date.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a healthcare provider for diagnosis, treatment decisions, and individualized dosing. Do not initiate or discontinue therapy without medical supervision.
Reviews
(Note: Fictional summaries based on common patient and clinician feedback.)
Dr. Elena Rostova, Endocrinologist: “In my practice, Amaryl has proven effective for patients requiring additional insulin secretion support. Its once-daily regimen is well tolerated, and titration is straightforward. Hypoglycemia remains a consideration, but with careful dosing, it is manageable.”
Marcus T., Patient: “Started Amaryl 2 mg last year. My morning sugars are consistently under 130 now. Occasional lightheadedness if I skip a meal, but keeping snacks handy helps. Overall, very satisfied.”
Clinical Study Summary (DERIVE Trial): Patients on glimepiride showed a mean HbA1c reduction of 1.5% from baseline over 6 months, with a low incidence of severe hypoglycemia.
Sarah J., Diabetes Educator: “Amaryl is a solid option for many of my type 2 patients. I emphasize the importance of regular meals and glucose monitoring to avoid lows.”
Real-World Evidence (Pooled Data): Demonstrated sustained glycemic control over 12 months in 68% of patients using glimepiride monotherapy.